Value through Innovation04 February 2016

A State-of-the-Art Research & Development Environment

At Boehringer Ingelheim, research & development is conducted at three major research & development sites (Ridgefield, USA, Biberach, Germany and Vienna, Austria) and two support centres (Kobe, Japan and Milan, Italy). During the last decade clinical research was conducted in 87 countries all over the world. Key to success in research & development are good people with the best scientific and technological knowledge, flexible thinking and good communication, who work well with their peers inside and outside the company.

Centres & Technologies

  • R&D Centres

    Boehringer Ingelheim's worldwide research, development and support centres.

  • Research Institute IMP

    The bridge between industry and academia is strengthened by the Research Institute of Molecular Pathology (IMP) in Vienna (Austria).

Drug Discovery Process

Druc discovery process

Oncology Websites

No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player